## Filters

### Category
- [All](/content/resources/index.html)
- [Publications & Abstracts](/content/resources-category/publications/index.html)
- [Case Studies](/content/resources-category/case-studies/index.html)
- [News](/content/resources-category/press-releases-announcements/index.html)
- [Articles](/content/resources-category/thought-leadership/index.html)
- [Reports](/content/resources-category/reports/index.html)
- [Webinars & Videos](/content/resources-category/webinars/index.html)

### Therapeutic Area
- Autoimmune
- Cardiovascular
- Chronic Pain
- Gastrointestinal
- Mental Health
- Metabolic & Endocrine
- Neurology
- Oncology
- Respiratory
- Sleep Disorders
- Substance Use Disorder
- Vaccines & Infectious Disease
- Women's Health

## News

### Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
- July 2, 2026  
  Among 119,000 surveyed individuals actively trying to lose weight, 24% had ever used prescription medication for weight management and 15% had ever used a GLP-1, suggesting significant room for continued market growth as adoption varies by age, gender, and income.
  
### ISPOR 2026 Recap: Understanding Health Between Visits
- May 27, 2026  
  Evidation’s research at ISPOR 2026 highlighted the growing need for direct, longitudinal patient data to better understand real-world outcomes.
  
### Creating a Complete View of Dermatology Care to Strengthen Brand and Portfolio Decisions to Drive Competitive Advantage
- April 22, 2026  
  Explore how longitudinal, multimodal real-world data collected through direct connections to individuals can sharpen brand positioning, clarify unmet need, and strengthen lifecycle and access strategy in competitive dermatology markets.
  
### Evidation Launches Interactive Dermatology Cohort; Shares Preliminary Real-World Insights
- March 26, 2026  
  New cohort is designed to address gaps in understanding treatment journeys across the full continuum of care. Insights show that consumer health products play a critical part in how individuals understand and manage their skin conditions.
  
### Enabling Next-Generation AI in Autoimmune R&D
- February 3, 2026  
  Explore how longitudinal, temporally relevant, multimodal data collected through direct connections with individuals can help unlock new opportunities across early R&D for immune-mediated diseases.
  
### Better data, better outcomes: Weight management
- September 16, 2024  
  Survey + wearable data from Evidation members about their weight management experiences have highlighted real-world priorities, challenges, and opportunities in this space.
  
### REVEAL, a prospective, observational study
- August 9, 2024  
  Evidation and partners aimed to examine the impact of paroxysmal nocturnal hemoglobinuria (PNH) and its treatment on patients’ daily lives by combining patient-reported outcomes with wearable technology.
  
### Equitable research drives equitable health care: The power of patient-reported outcomes (PROs)
- July 30, 2024  
  Learn how integrating participant-reported outcome (PRO) data with social determinants of health (SDOH) can identify and address disparities in access to care, treatment outcomes, and satisfaction with health care.